News

Indrayani Biotech Ltd share price tumbled by 8.91% to Rs 7.16. The Company`s net profit saw a strong growth of 808.33% to Rs 1.09 crore, while revenue from operations gained significantly 107.88% to Rs 72.78 crore in Q1FY26 over Q4FY25. The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 57073.02 crore, gaining 6.64%. It has improved by 0.99% over last one week and gained upto 1.62% in last one month while the market capitalization of Indrayani Biotech Ltd has slipped by 9.25% and 31.03% in the same period respectively. Profit before tax (PBT) of Indrayani Biotech Ltd stood at Rs 0.97 crore in Q1 FY26, crashing by 88.34% year-on-year, and tumbling by 792.86% quarter-on-quarter. EBITDA came in at Rs 3 crore, plunging by 138.62% YoY and surging by 67.86% sequentially. Total expenses witnessed a sharp rise of 110.35% to Rs 69.92 crore in Q1FY26 over Q1FY25. During the quarter, cost of materials consumed stood at Rs 51.38 crore, jumping 96.86% YoY, while employee benefits expense was at Rs 7.49 crore, witnessing a strong rise of 134.06% YoY. For the TTM ended FY26, revenue from operations plunged by 21.66% to Rs 130.23 crore, while net profit witnessed a sharp fall of 158.64% to Rs 6.11 crore, compared to previous TTM. EBITDA surged by 2080% to Rs 3.13 crore, and PBT tanked by 152.32% to Rs 5.74 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 6.74 crore in FY26, as against Rs 30.35 crore in FY25. Indrayani Biotech Ltd crashed 50.24% in last one year, underperforming the benchmark BSE Sensex which has softened by 4.36% during the same period.

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 9 April 2026.

Net profit of Indrayani Biotech declined 75.00% to Rs 0.06 crore in the quarter ended December 2025 as against Rs 0.24 crore during the previous quarter ended December 2024. Sales rose 102.14% to Rs 35.01 crore in the quarter ended December 2025 as against Rs 17.32 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales35.0117.32 102 OPM %7.9716.86 - PBDT1.151.89 -39 PBT0.140.43 -67 NP0.060.24 -75 Powered by Capital Market - Live News

Indrayani Biotech will hold a meeting of the Board of Directors of the Company on 26 February 2026.Powered by Capital Market - Live News

Net profit of Indrayani Biotech declined 25.41% to Rs 0.91 crore in the quarter ended September 2025 as against Rs 1.22 crore during the previous quarter ended September 2024. Sales rose 16.68% to Rs 35.95 crore in the quarter ended September 2025 as against Rs 30.81 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales35.9530.81 17 OPM %6.8216.59 - PBDT2.363.99 -41 PBT1.061.20 -12 NP0.911.22 -25 Powered by Capital Market - Live News